Literature DB >> 33749411

Therapeutic modulation methods of gut microbiota and gut-liver axis.

Ayfer Beyaz Coşkun1, Adviye Gülçin Sağdiçoğlu Celep2.   

Abstract

Liver diseases are considered global health problems that cause more than 1 million deaths each year. Due to the increase in the prevalence of liver diseases worldwide, studies on different treatment methods have increased. Some of these methods is diagnostic and therapeutic applications based on the examination of the intestinal and intestinal microbiota. In this study, research articles, systematic review and review in the literature were examined in order to determine gut-liver axis relationship and treatment methods for liver diseases with gut modulation methods. Studies related to the subject have been searched in Google Scholar and Pubmed databases. The keywords "liver disease" and "gut-liver axis" and "microbiota" and "gut modulation methods" or "probiotic" or "prebiotic" or "symbiotic" or "antibiotic" or "bile acid regulation" or "adsorbent" or "fecal microbiota transplantation" were used in the searches. Improvements have been achieved in biomarkers of liver diseases by providing intestinal modulation with probiotic, prebiotic, symbiotic, antibiotic and adsorbents applications, bile acid regulation and fecal microbiota transplantation. In the results of experimental and clinical studies, it was seen that the therapeutic potential of the treatments performed by applying probiotics, prebiotics and symbiotics was higher.

Entities:  

Keywords:  Gut modulation methods; liver disease; prebiotic; probiotic; symbiotic

Mesh:

Substances:

Year:  2021        PMID: 33749411     DOI: 10.1080/10408398.2021.1902263

Source DB:  PubMed          Journal:  Crit Rev Food Sci Nutr        ISSN: 1040-8398            Impact factor:   11.208


  2 in total

Review 1.  The Gut Microbiota: A Novel Player in Autoimmune Hepatitis.

Authors:  Zilu Cheng; Ling Yang; Huikuan Chu
Journal:  Front Cell Infect Microbiol       Date:  2022-07-11       Impact factor: 6.073

Review 2.  Gut Microbiota-A Future Therapeutic Target for People with Non-Alcoholic Fatty Liver Disease: A Systematic Review.

Authors:  Roberta Forlano; Mathuri Sivakumar; Benjamin H Mullish; Pinelopi Manousou
Journal:  Int J Mol Sci       Date:  2022-07-27       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.